Composition for immunostimulation

Details Composition for immunostimulation Composition for immunostimulation

2011-05-17

2011-05-17

Ford, Vanessa L. (Department: 1645)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

C424S093400, C424S184100, C424S234100, C435S041000, C530S300000

Reexamination Certificate

active

07943124

ABSTRACT:
The present invention relates to a composition for immunostimulation useful for promoting IgA and secretory component productions in mucosal tissues, comprising, alone or in combination, a cell ofbifidobacteriumbelonging toBifidobacterium bifidumor a processed product thereof, wherein thebifidobacteriumhas an activity to stimulate secretory component production and a high activity to stimulate IgA production, for example, it is aBifidobacterium bifidumOLB 6377 strain orBifidobacterium bifidumOLB 6378 strain.

REFERENCES:
patent: 5192685 (1993-03-01), Yasui et al.
patent: 2004/0110270 (2004-06-01), Dennin et al.
patent: 0640349 (1995-03-01), None
patent: 0640 349 (1995-09-01), None
patent: 2-280059 (1990-11-01), None
patent: 4-342533 (1992-11-01), None
patent: 7-069907 (1995-03-01), None
patent: 7-106142 (1995-11-01), None
patent: 2002-255853 (2002-09-01), None
patent: 2002-255853 (2002-09-01), None
patent: 2003-201239 (2003-07-01), None
patent: 2004-262773 (2004-09-01), None
patent: 7-061934 (2005-03-01), None
patent: 2005-089388 (2005-04-01), None
Park et al (Cell Immunology, 2002, 219,(1) p. 22-27).
Manufacturer's Product Description for MTT Cell Viability Assay Kit, Biotium Inc.
Partial English—language Translation of JP 2002-255853A (Eiko et al).
Perrier et al., “Glycans on Secretory Component Participate in Innate Protection against Mucosal Pathogens”Journal of Biological Chemistry281(20):14280-14287, 2006.
Gang MA et al., “Study on Bifidobacterial Milk,” Food & Fermentation Industries, No. 1, pp. 13-18, including an English language Abstract, 1992.
Chinese Office Action issued Mar. 15, 2010 in connection with patent family member Chinese Patent Application No. 200680010464.4, along with a partial English language translation thereof.
Park et al., EncapsulatedBifidobacterium bifidumpotentiates intestinal IgA production,Cell. Immunol., vol. 219, No. 1, pp. 22-27 (2002).
Qiao et al., Immune Responses in Rhesus Rotavirus-Challenged Balb/c Mice Treated with Bifidobacteria and Prebiotic Supplements,Pediatric Research, vol. 51, No. 6, pp. 750-755 (2002).
English Language Abstract of JP 2002-255853, Sep. 11, 2002.
English Language Abstract of JP 2005-089388, Apr. 7, 2005.
English Language Abstract of JP 7-061934, Mar. 7, 1995.
English Language Abstract of JP 4-342533, Nov. 30, 1992.
English Language Abstract of JP 2-280059, Nov. 16, 1990.
Hosono et al., Men'ekikei to Sogosayo suru Chonai Saikin (Probiotics), Allergology, vol. 18, No. 6, pp. 483-489 (2004), along with a partial English-language translation thereof.
Ko et al.,Bifidobacterium bifidumExhibits a Lipopolysaccharide-Like Mitogenic Activity for Murine B Lymphocytes,J. Dairy Science, vol. 82, No. 9, pp. 1869-1876 (1999).
English Language Abstract of JP 2004-262773, Sep. 24, 2004.
English Language Abstract of JP 2003-201239, Jul. 18, 2003.
English Language Abstract of patent family member JP 2-280059, Nov. 16, 1990.
English Language Abstract of JP 7-069907, Mar. 14, 1995.
Takahashi et al., Effects of Orally IngestedBifidobacterium longumon the Mucosal IgA Response of Mice to Dietary Antigens,Biosci. Biotechnol. Biochem., vol. 62, No. 1, pp. 10-15 (1998).
Giugliano et al., Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenicEscherichia coli, J. Med. Microbiol., vol. 42, pp. 3-9 (1995).
Dallas et al., Binding ofClostridium difficiletoxin A to human milk secretory component,J. Med. Microbiol., vol. 47, pp. 879-888 (1998).
Johansen et al., Absence of Epithelial Immunoglobulin A Transport, with Increased Mucosal Leakiness, in Polymeric Immunoglobulin Receptor/Secretory Component—deficient Mice,J. Exp. Med., vol. 190, No. 7, pp. 915-921 (1999).
Ha et al., Depression in the Quantity of Intestinal Secretory IgA and in the Expression of the Polymeric Immunoglobulin Receptor in Caloric Deficiency of the Weanling Mouse,Lab. Invest., vol. 78, No. 10, pp. 1255-1266 (1998).
Suzuki et al., Rapid Preparation of Functional Murine Payer's Patch Cells,Bifidobacteria Microflora, vol. 9, No. 2, pp. 87-98 (1990).
Blanch et al., Cutting Edge: Coordinate Regulation of IFN Regulatory Factor-1 and the Polymeric Ig Receptor by Proinflammatory Cytokines,J. Immunol., vol. 162, pp. 1232-1235 (1999).

Affiliated with

Also associated with

Rating

Composition for immunostimulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for immunostimulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for immunostimulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2636672